NewGenIvf
NIVF
1 hedge funds and large institutions have $15 invested in NewGenIvf in 2026 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 4 closing their positions.
75% less funds holding
Funds holding: 4 → 1 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
100% less capital inflows, than outflows
Capital inflows: $201 | Capital outflows: $139K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SBI Securities
Tokyo,
Japan
|
+$201 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HRT Financial
New York
|
-$94K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$32.3K |
| 3 |
XTX Topco
George Town,
Cayman Islands
|
-$7.54K |
| 4 |
Tower Research Capital (TRC)
New York
|
-$5.36K |
| 5 |
Caitong International Asset Management
Hong Kong
|
-$1 |
NIVF Hedge Fund Activity: Q3 2026 in Review
1 of the 8,192 institutional investors tracked by Wall St. Rank reported a position in NewGenIvf (NIVF) for Q3 2026, worth a combined $15 — down 100% from $139K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NIVF and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was SBI Securities, opening a new position worth an estimated $201. The largest seller was HRT Financial, exiting entirely with an estimated $94K sold.
- 1 institutional investor held NewGenIvf (NIVF) as of Q3 2026, down from 4 in Q2 2026.
- Funds reported $15 of NewGenIvf stock for Q3 2026, down 100% quarter-over-quarter.
- 1 fund opened new NewGenIvf positions in Q3 2026 and 4 closed out, a net change of -3 holders.
- The largest NewGenIvf buyer in Q3 2026 was SBI Securities, an estimated $201 added.
- The largest NewGenIvf seller in Q3 2026 was HRT Financial, an estimated $94K sold.
Based on aggregated 13F filings for Q3 2026.